Literature DB >> 21120212

Long-term survival in a patient with acute promyelocytic leukemia with isolated meningeal relapse.

Se Hyung Kim1, Jina Yun, Hyun Jung Kim, Chan Kyu Kim, Sung Kyu Park, Dae Sik Hong.   

Abstract

The meningeal involvement is rare in acute promyelocytic leukemia. We experienced a 39-year-old woman who achieved complete remission with all-trans retinoic acid, idarubicin and cytarabine therapy. Several months later, she complained of non-specific headache. Her complete blood cell count was normal, but magnetic resonance image of brain revealed focal meningeal enhancement and cerebrospinal fluid showed leukemic promyelocytes and PML/RARA rearrangement. Bone marrow study showed hematologic, cytogenetic and molecular remission. She was treated with intrathecal and systemic chemotherapy and whole brain radiotherapy. The patient has survived for 68 months since the last systemic chemotherapy.

Entities:  

Keywords:  APL; CNS; Extramedullary involvement

Year:  2010        PMID: 21120212      PMCID: PMC2983040          DOI: 10.5045/kjh.2010.45.3.208

Source DB:  PubMed          Journal:  Korean J Hematol        ISSN: 1738-7949


  14 in total

1.  Parotid and central nervous system relapse during complete hematologic remission in acute promyelocytic leukemia.

Authors:  J R Mesa; E Espinosa; R Losada; C Hernandez; G Martinez; P Hernandez
Journal:  Haematologica       Date:  1999-06       Impact factor: 9.941

2.  Acute promyelocytic leukemia relapse in the central nervous system during hematologic and molecular remission.

Authors:  E Anguita; A Villegas; F A González; J Díaz-Mediavilla; F Lo Coco
Journal:  Am J Hematol       Date:  1999-02       Impact factor: 10.047

Review 3.  Current pharmacological treatment approaches to central nervous system leukaemia.

Authors:  S M Blaney; F M Balis; D G Poplack
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

Review 4.  Extramedullary acute promyelocytic leukemia.

Authors:  P H Wiernik; R De Bellis; P Muxi; J P Dutcher
Journal:  Cancer       Date:  1996-12-15       Impact factor: 6.860

5.  Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto.

Authors:  G Specchia; F Lo Coco; M Vignetti; G Avvisati; P Fazi; F Albano; F Di Raimondo; B Martino; F Ferrara; C Selleri; V Liso; F Mandelli
Journal:  J Clin Oncol       Date:  2001-10-15       Impact factor: 44.544

6.  Determinants of cerebrospinal fluid arsenic concentration in patients with acute promyelocytic leukemia on oral arsenic trioxide therapy.

Authors:  Wing-Yan Au; Sidney Tam; Bonnie M Fong; Yok-Lam Kwong
Journal:  Blood       Date:  2008-08-14       Impact factor: 22.113

7.  Extramedullary involvement in patients with acute promyelocytic leukemia: a report of seven cases.

Authors:  V Liso; G Specchia; E M Pogliani; G Palumbo; D Mininni; V Rossi; E Teruzzi; A Mestice; M R Coppi; A Biondi
Journal:  Cancer       Date:  1998-10-15       Impact factor: 6.860

8.  All-trans-retinoic acid increases adhesion to endothelium of the human promyelocytic leukaemia cell line NB4.

Authors:  M Marchetti; A Falanga; S Giovanelli; E Oldani; T Barbui
Journal:  Br J Haematol       Date:  1996-05       Impact factor: 6.998

Review 9.  Meningeal relapse in a patient with acute promyelocytic leukemia: a case report and review of the literature.

Authors:  Sung Hwa Bae; Hun Mo Ryoo; Hee Soon Cho; Jae Lyun Lee; Kyung Hee Lee; Myung Soo Hyun
Journal:  J Korean Med Sci       Date:  2004-04       Impact factor: 2.153

10.  Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation.

Authors:  I Saiki; H Fujii; J Yoneda; F Abe; M Nakajima; T Tsuruo; I Azuma
Journal:  Int J Cancer       Date:  1993-04-22       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.